Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
J Cosmet Dermatol ; 17(2): 246-257, 2018 Apr.
Article in English | MEDLINE | ID: mdl-28670794

ABSTRACT

BACKGROUND: Skin whitening products, used for ages by Asian people for cultural and esthetic purposes, are very popular nowadays in Western countries as well, where the need to inhibit skin spots after sun exposure has become not only a cosmetic but also a health-related issue. Thus, the development of effective and safe depigmenting agents derived from natural products gets continuous attention by cosmetic brands and consumers. OBJECTIVES: The aim of this study was to determine the effects of two preparations, obtained from the hairy root cultures of the species Brassica rapa, on melanogenesis and the expression of the extracellular matrix proteins involved in a correct pigment distribution. METHODS: The two preparations, obtained by water-ethanol extraction and by digestion of cell-wall glycoproteins of the root cells, were chemically characterized and tested on skin cell cultures and on human skin explants to investigate on their dermatological activities. RESULTS: Both the extracts were able to decrease melanin synthesis pathway in melanocytes and modulate the expression of genes involved in melanin distribution. One of the extracts was also effective in inducing the expression of laminin-5 and collagen IV, involved into the maintenance of tissue integrity. The two extracts, when tested together on human skin explants, demonstrated a good synergic hypopigmenting activity. CONCLUSIONS: Taken together, the results indicate that the extracts from B. rapa root cultures can be employed as cosmetic active ingredients in skin whitening products and as potential therapeutic agents for treating pigmentation disorders.


Subject(s)
Brassica rapa , Melanins/biosynthesis , Plant Extracts/pharmacology , Skin Lightening Preparations/pharmacology , Skin Pigmentation/drug effects , Skin/drug effects , Cell Adhesion Molecules/metabolism , Cell Line, Tumor , Collagen Type IV/metabolism , Extracellular Matrix/drug effects , Extracellular Matrix/metabolism , Humans , Keratinocytes/metabolism , Laminin/metabolism , Melanins/metabolism , Melanocytes/metabolism , Microphthalmia-Associated Transcription Factor/genetics , Plant Roots , Protein Biosynthesis/drug effects , Kalinin
2.
Cell Biol Toxicol ; 34(4): 321-332, 2018 08.
Article in English | MEDLINE | ID: mdl-29127567

ABSTRACT

The root of Actinidia chinensis, as traditional Chinese medicine, has been shown to inhibit cell proliferation in numerous cancer cells. However, the mechanisms underlying its inhibitory activity remain unclear. Death rates of hepatocellular carcinoma (HCC) are increasing, but therapies for advanced HCC are not well developed. We choose the extract from root of Actinidia chinensis (ERAC) to treat the HCC cell lines in vitro, displaying distinct effects on cell proliferation, S-phase cell cycle arrest, and apoptosis. LAMB3, the gene encoding laminin subunit beta-3, plays a key role in the proliferation suppression and S-phase cell cycle arrest of HepG2 cells treated with ERAC. The downstream genes ITGA3, CCND2, and TP53 in LAMB3 pathway show the same response to ERAC as LAMB3. Thus, LAMB3 pathways, along with extracellular matrix-receptor interaction, pathways in cancer, and focal adhesion, are involved in the ERAC-induced suppressive response in HepG2.


Subject(s)
Actinidia/chemistry , Carcinoma, Hepatocellular/drug therapy , Cell Adhesion Molecules/metabolism , Liver Neoplasms/drug therapy , Plant Extracts/therapeutic use , Plant Roots/chemistry , Apoptosis/drug effects , Apoptosis/genetics , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/pathology , Cell Adhesion Molecules/genetics , Cell Cycle Checkpoints/drug effects , Cell Cycle Checkpoints/genetics , Cell Proliferation/drug effects , Gene Expression Regulation, Neoplastic/drug effects , Hep G2 Cells , Humans , Liver Neoplasms/genetics , Liver Neoplasms/pathology , Models, Biological , Plant Extracts/pharmacology , S Phase/drug effects , S Phase/genetics , Signal Transduction/drug effects , Kalinin
3.
Exp Cell Res ; 324(2): 172-82, 2014 Jun 10.
Article in English | MEDLINE | ID: mdl-24726610

ABSTRACT

Hemidesmosomes are cell-to-matrix adhesion complexes anchoring keratinocytes to basement membranes. For the first time, we present a method to prepare a fraction from human cultured cells that are highly enriched in hemidesmosomal proteins. Using DJM-1 cells derived from human squamous cell carcinoma, accumulation of hemidesmosomes was observed when these cells were cultured for more than 10 days in a commercial serum-free medium without supplemental calcium. Electron microscopy demonstrated that numerous electron-dense adhesion structures were present along the basal cell membranes of DJM-1 cells cultured under the aforementioned conditions. After removing cellular materials using an ammonia solution, hemidesmosomal proteins and deposited extracellular matrix were collected and separated by electrophoresis. There were eight major polypeptides, which were determined to be plectin, BP230, BP180, integrin α6 and ß4 subunits, and laminin-332 by immunoblotting and mass spectrometry. Therefore, we designated this preparation as a hemidesmosome-rich fraction. This fraction contained laminin-332 exclusively in its unprocessed form, which may account for the promotion of laminin deposition, and minimal amounts of Lutheran blood group protein, a nonhemidesmosomal transmembrane protein. This hemidesmosome-rich fraction would be useful not only for biological research on hemidesmosomes but also for developing a serum test for patients with blistering skin diseases.


Subject(s)
Carcinoma, Squamous Cell/ultrastructure , Hemidesmosomes/ultrastructure , Skin Neoplasms/ultrastructure , Autoantigens/isolation & purification , Autoantigens/metabolism , Carrier Proteins , Cell Adhesion Molecules/isolation & purification , Cell Adhesion Molecules/metabolism , Cell Fractionation , Cell Line, Tumor , Cytoskeletal Proteins , Dystonin , Hemidesmosomes/chemistry , Humans , Integrin alpha6/isolation & purification , Integrin alpha6/metabolism , Integrin beta4/isolation & purification , Integrin beta4/metabolism , Membrane Glycoproteins/isolation & purification , Membrane Glycoproteins/metabolism , Nerve Tissue Proteins , Non-Fibrillar Collagens/isolation & purification , Non-Fibrillar Collagens/metabolism , Plectin/isolation & purification , Plectin/metabolism , Subcellular Fractions , Kalinin , Collagen Type XVII
4.
Colloids Surf B Biointerfaces ; 114: 284-93, 2014 Feb 01.
Article in English | MEDLINE | ID: mdl-24216619

ABSTRACT

The present paper describes a study on laminin interaction with the surface of two alumina-zirconia composites with different percentages of ZrO2, both with submicrometric grain size. As major molecules within the basement membrane (BM), laminins are important protein fragments for epithelial cell adhesion and migration. On the other hand, alumina-zirconia composites are very attractive materials for dental applications due to their esthetic and mechanical properties. X-Ray photoelectron spectroscopy and atomic force microscopy were used to study the adsorption of two types of laminin, laminin-1 (Ln-1) and laminin-5 (Ln-5), onto the ceramics surfaces. The in vitro cell response was determined by intracellular phosphorylation of major kinases. Ceramics samples functionalized with laminins showed better cellular activation than untreated specimens; furthermore, cellular activation was found to be greater for the composite with higher percentage in zirconia when functionalized with Ln-5, whereas the adsorption of Ln-1 resulted in a greater activation for the alumina-rich oxide.


Subject(s)
Aluminum Oxide/chemistry , Cell Adhesion Molecules/pharmacology , Cells/cytology , Dentistry , Laminin/pharmacology , Zirconium/chemistry , Adsorption/drug effects , Animals , Cell Adhesion/drug effects , Cells/drug effects , Cytokines/metabolism , HeLa Cells , Humans , Mice , Microscopy, Atomic Force , Phosphorylation/drug effects , Photoelectron Spectroscopy , Surface Properties , Kalinin
5.
Acta Derm Venereol ; 86(4): 292-9, 2006.
Article in English | MEDLINE | ID: mdl-16874412

ABSTRACT

Drug screening procedures should preferably utilize experimental settings mimicking the in vivo situation. The aim of this study was to evaluate a skin explant model as a tool to identify topical agents with anti-proliferative properties in human epidermis. Re-epithelialization was initiated from a skin punch biopsy explanted onto de-epidermized dermis and cultured at the air-liquid interface in the presence of epidermal growth factor receptor inhibitor PKI166, tacrolimus or established topical anti-psoriatic drugs: betamethasone, calcipotriol, dithranol and tazarotene. Neo-epidermal extension was traced by fluorescence microscopy prior to histomorphometric analysis. PKI166 at 1 microM decreased the mean radial outgrowth rate (-19%), frequency of BrdU-positive (-37%) and laminin 5-positive (-45%) cells, indicating reduced proliferation and migration of neo-epidermal keratinocytes. However, the papillomatosis index and epithelial thickness were not significantly affected. Calcipotriol at 1 microM had a similar effect on the outgrowth rate (-15%) and fraction of laminin 5-stained keratinocytes (-40%). Furthermore, calcipotriol significantly reduced mean neo-epidermal thickness. Equimolar concentrations of the other test compounds had no apparent effect on histology or outgrowth parameters. This study exemplifies the versatility of combined dynamic and morphological analysis and emphasizes the potential of epidermal growth factor receptor-directed inhibition in hyperproliferative disorders of the epidermis.


Subject(s)
Cell Proliferation/drug effects , Dermatologic Agents/pharmacology , Epithelial Cells/drug effects , Skin/cytology , Apoptosis/drug effects , Cell Adhesion Molecules/metabolism , Cell Movement/drug effects , Drug Evaluation, Preclinical , Epidermal Cells , Epidermis/drug effects , Epithelial Cells/cytology , Humans , Immunohistochemistry , In Vitro Techniques , Keratinocytes/cytology , Keratinocytes/drug effects , Keratinocytes/metabolism , Keratinocytes/physiology , Microscopy, Fluorescence , Psoriasis , Skin/drug effects , Kalinin
6.
Brain Res ; 1076(1): 231-7, 2006 Mar 03.
Article in English | MEDLINE | ID: mdl-16480689

ABSTRACT

Hyperbaric oxygen (HBO) has been shown to preserve the integrity of the blood-brain barrier after cerebral ischemia. However, the underlying molecular mechanisms are currently unknown. We examined the effect of HBO on postischemic expression of the basal laminar component laminin-5 and on plasma matrix metalloproteinase-9 (MMP) levels. Wistar rats underwent occlusion of the middle cerebral artery (MCAO) for 2 h. With a delay of 45 min after filament introduction, animals breathed either 100% O2 at 1.0 atmosphere absolute (ata; NBO) or at 3.0 ata (HBO) for 1 h in an HBO chamber. Laminin-5 expression was quantified on immunohistochemical sections after 24 h of reperfusion. Plasma MMP-9 levels were measured using gelatin zymography before MCAO as well as 0, 6 and 24 h after reperfusion. Immunohistochemistry 24 h after ischemia revealed a decrease of vascular laminin-5 staining in the ischemic striatum to 43 +/- 26% of the contralateral hemisphere in the NBO group which was significantly attenuated to 73 +/- 31% in the HBO group. Densitometric analysis of zymography bands yielded significantly larger plasma MMP-9 levels in the NBO group compared to the HBO group 24 h after ischemia. In conclusion, HBO therapy attenuates ischemic degradation of cerebral microvascular laminin-5 and blocks postischemic plasma MMP-9 upregulation.


Subject(s)
Cell Adhesion Molecules/metabolism , Hyperbaric Oxygenation , Ischemic Attack, Transient/metabolism , Ischemic Attack, Transient/therapy , Matrix Metalloproteinase 9/blood , Animals , Disease Models, Animal , Functional Laterality , Immunohistochemistry/methods , Ischemic Attack, Transient/pathology , Magnetic Resonance Imaging/methods , Male , Rats , Rats, Wistar , Reperfusion/methods , Time Factors , Kalinin
7.
Pigment Cell Res ; 15(6): 426-32, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12453184

ABSTRACT

It is known that the migration of melanocyte precursors (melanoblasts) from the outer root sheath of hair follicles into clinically depigmented epidermis is crucial to the repigmentation of vitiliginous skin treated with photochemotherapy (PUVA), but such migratory cells must penetrate extracellular matrix tissue barriers in vivo. To test the hypothesis that matrix metalloproteinases (MMPs) are required for this process, we determined whether cultured melb-a cells, an immortal line of melanoblasts isolated from neonatal mouse epidermis, express and secrete MMPs and whether a synthetic metalloproteinase inhibitor, GM6001 (Galardin), inhibits their migratory behavior in vitro. Reverse transcriptase-polymerase chain reaction and Western blotting were used to determine the patterns of MMP expression by melanoblasts at the mRNA and protein levels, respectively. The proteolytic activities of MMPs secreted into the culture medium were assessed by gelatin zymography. The capacity of melanoblasts to migrate on fibronectin, laminin or laminin-5 substrates was estimated using Transwell migration assays. The results show that MMP2, MMP9 and MT1-MMP transcripts are expressed by these melanoblasts, but only MMP2 is secreted and activated in the extracellular environment. Although the therapeutic efficacy of PUVA in stimulating repigmentation of vitiliginous skin might derive from direct effects of UVA and/or 8-methoxypsoralen (8MOP), recent studies have shown that keratinocyte-derived factors induced by ultraviolet radiation, especially alpha-melanocyte stimulating hormone (alpha MSH), play a major role in regulating melanocyte function. Therefore, we also examined whether 8MOP and/or alphaMSH are involved in the up-regulation of MMP2 expression in melanoblasts. Western blotting and zymographic analyses revealed that MMP2 synthesis and secretion were induced by 8MOP and/or by alpha MSH. This induction of MMP2 resulted in significant increases of migration by melanoblasts on laminin or on laminin-5 substrates, while concomitant treatment with GM6001 blocked that induced migration. Taken together, these results suggest the importance of MMP2 in melanoblast migration and in the response to PUVA therapy.


Subject(s)
Cell Movement/physiology , Matrix Metalloproteinase 2/metabolism , Melanocytes/cytology , Melanocytes/enzymology , PUVA Therapy , Vitiligo/drug therapy , Animals , Cell Adhesion Molecules/pharmacology , Cells, Cultured , Dipeptides/pharmacology , Enzyme Induction/drug effects , In Vitro Techniques , Laminin/pharmacology , Matrix Metalloproteinase 2/genetics , Methoxsalen/pharmacology , Mice , Mice, Inbred C57BL , Protease Inhibitors/pharmacology , Vitiligo/pathology , alpha-MSH/pharmacology , Kalinin
SELECTION OF CITATIONS
SEARCH DETAIL